Is this you? Create Your Porfile
Avatar

Amy Hankin

National Institutes of Health

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Amy Hankin is active.

Explore More

Publication

Featured researches published by Amy Hankin.

Journal of Clinical Oncology | 2013

A phase I/II study of ABT-888 in combination with 5-fluorouracil (5-FU) and oxaliplatin (Ox) in patients with metastatic pancreatic cancer (MPC).

Michael J. Pishvaian; Hongkun Wang; Tingting Zhuang; Aiwu Ruth He; Jimmy J. Hwang; Amy Hankin; Lisa Ley; Keisha White; Susan Joy Littman; Louis M. Weiner; John Marshall; Jonathan R. Brody

Journal of Clinical Oncology | 2011

A phase II study of the PARP inhibitor ABT-888 plus temozolomide in patients with heavily pretreated, metastatic colorectal cancer.

Michael J. Pishvaian; Rebecca S. Slack; A. Witkiewicz; Aiwu Ruth He; J. J. Hwang; Amy Hankin; K. Dorsch-Vogel; D. Kuda; T. McAndrew; Louis M. Weiner; John Marshall; Jonathan R. Brody

Journal of Clinical Oncology | 2017

A phase II study of the anti-programmed death ligand-1 antibody durvalumab (D; MEDI4736) in combination with PARP inhibitor, olaparib (O), in metastatic castration-resistant prostate cancer (mCRPC).

Fatima Karzai; Ravi A. Madan; Helen Owens; Amy Hankin; Anna Couvillon; Nicole Houston; Farhad Fakhrejahani; Marijo Bilusic; Marc R. Theoret; Lisa M Cordes; Jane B. Trepel; Daniel C. Edelman; Paul S. Meltzer; James L. Gulley; William L. Dahut; Jung-Min Lee

Journal of Clinical Oncology | 2011

A phase I/II study of the PARP inhibitor, ABT-888 plus 5-fluorouracil and oxaliplatin (modified FOLFOX-6) in patients with metastatic pancreatic cancer.

Michael J. Pishvaian; Rebecca S. Slack; A. Witkiewicz; Aiwu Ruth He; J. J. Hwang; Amy Hankin; Lisa Ley; S. K. Apte; Susan Joy Littman; Louis M. Weiner; John Marshall; Jonathan R. Brody

Journal of Clinical Oncology | 2018

A phase 2 study of olaparib and durvalumab in metastatic castrate-resistant prostate cancer (mCRPC) in an unselected population.

Fatima Karzai; Ravi A. Madan; Helen Owens; Anna Couvillon; Amy Hankin; Monique Williams; Marijo Bilusic; Lisa M Cordes; Jane B. Trepel; Keith Killian; Paul S. Meltzer; James L. Gulley; Jung-Min Lee; William L. Dahut

Journal of Clinical Oncology | 2017

Combination of PDL-1 and PARP inhibition in an unselected population with metastatic castrate-resistant prostate cancer (mCRPC).

Fatima Karzai; Ravi A. Madan; Helen Owens; Amy Hankin; Anna Couvillon; Lisa M Cordes; Farhad Fakhrejahani; Nicole Houston; Jane B. Trepel; Clara C. Chen; Daniel C. Edelman; Paul S. Meltzer; Seth M. Steinberg; James L. Gulley; William L. Dahut; Jung-Min Lee

Journal of Clinical Oncology | 2016

Clinical and immunologic impact of short course enzalutamide without androgen deprivation therapy for biochemically recurrent prostate cancer.

Ravi A. Madan; Renee N. Donahue; Harpreet Singh; Fatima Karzai; Marc R. Theoret; Christopher R. Heery; Julius Strauss; Nancy Harold; Anna Couvillon; Jennifer L. Marte; Amy Hankin; Italia Grenga; Guinevere Chun; Inger Rosner; David G. McLeod; Lisa M Cordes; William D. Figg; William L. Dahut; Jeffrey Schlom; James L. Gulley

Journal of Clinical Oncology | 2018

CRLX101 plus olaparib in patients with metastatic castration-resistant prostate cancer.

Gang Chen; Fatima Karzai; Ravi A. Madan; Lisa M Cordes; Marijo Bilusic; Helen Owens; Amy Hankin; Monique Williams; Anna Couvillon; James L. Gulley; William L. Dahut; Anish Thomas

Journal of Clinical Oncology | 2018

Combination of a therapeutic cancer vaccine and immune checkpoint inhibitors in prostate cancer.

Ravi A. Madan; Marijo Bilusic; Julius Strauss; Fatima Karzai; Lisa M Cordes; Philip M. Arlen; Marc R. Theoret; Myrna Rauckhorst; Colin C. Pritchard; Houssein Talal Abdul Sater; Anna Couvillon; Amy Hankin; Monique Williams; William L. Dahut; Jeffrey Schlom; James L. Gulley

Journal of Clinical Oncology | 2018

Immunotherapy for biochemically recurrent prostate cancer.

Ravi A. Madan; Fatima Karzai; Marijo Bilusic; Julius Strauss; Susan F. Slovin; Lauren C. Harshman; Marc R. Theoret; Philip M. Arlen; Myrna Rauckhorst; Anna Couvillon; Amy Hankin; Monique Williams; Philip W. Kantoff; William L. Dahut; Jeffrey Schlom; James L. Gulley

Explore More

Collaboration

Dive into the Amy Hankin's collaboration.

Top Co-Authors
Avatar

Anna Couvillon

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

Fatima Karzai

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

James L. Gulley

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

Ravi A. Madan

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

William L. Dahut

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

Lisa M Cordes

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

Marc R. Theoret

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

Marijo Bilusic

Fox Chase Cancer Center

View shared research outputs
Top Co-Authors
Avatar

Jeffrey Schlom

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

Julius Strauss

National Institutes of Health

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge